Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aspira Women's Health Inc AWHL

Healthcare Biotechnology
Aspira Women's Health Inc. is engaged in the discovery, development, and commercialization of noninvasive, artificial intelligence (AI)-powered tests to aid in the diagnosis of gynecologic diseases. The Company's portfolio includes OvaWatch and the Ova1Plus workflow, offered to clinicians as OvaSuite. OvaWatch is used to assess ovarian cancer risk for women with an adnexal mass where their... see more

Recent & Breaking News (OTCQB:AWHL)

Aspira Women's Health Inc. Announces Proposed Public Offering

GlobeNewswire August 22, 2022

Aspira Women's Health Hosting Women's Health Webinar on Ovarian Cancer Risk Assessments Utilizing Multivariant Index Assay

GlobeNewswire August 18, 2022

Aspira Women's Health Reports Second Quarter 2022 Financial Results

GlobeNewswire August 10, 2022

Aspira Women's Health to Announce Second Quarter 2022 Financial Results and Host Conference Call on Wednesday, August 10

GlobeNewswire August 1, 2022

Aspira Women's Health Announces Appointment of Two New Board Members

GlobeNewswire June 23, 2022

Aspira Women's Health Announces Publication of Paper Validating OvaWatch(TM) Algorithm in the Detection of Ovarian Cancer

GlobeNewswire June 16, 2022

36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022

ACCESS Newswire May 16, 2022

Aspira Women's Health to Participate in the Upcoming Investor Conferences

GlobeNewswire May 12, 2022

Aspira Women's Health Reports First Quarter 2022 Financial Results

GlobeNewswire May 11, 2022

Aspira Women's Health to Announce First Quarter 2022 Financial Results and Host Conference Call on Wednesday, May 11

GlobeNewswire April 29, 2022

Aspira Women's Health Reports Fourth Quarter and Full Year 2021 Financial Results

GlobeNewswire March 23, 2022

Aspira Women's Health to Announce Year End 2021 Financial Results and Host Conference Call on Wednesday, March 23

GlobeNewswire March 15, 2022

Aspira Women's Health Announces Appointment of Celeste Fralick, Ph.D., to its Board of Directors

GlobeNewswire February 28, 2022

Valerie Palmieri Elevated to Executive Chair of the Board; Nicole Sandford Appointed President and CEO

GlobeNewswire February 24, 2022

Aspira Women's Health, Inc. Expands Senior Leadership Team with Addition of Mr. Michael Newton as Head of Sales and Marketing

GlobeNewswire February 22, 2022

Aspira Women's Health to Participate in the Upcoming Winter Wonderland Best Ideas Conference

GlobeNewswire February 8, 2022

Aspira Women's Health Announces the Addition of 465,000 Covered Lives Through Medicaid Credentialing

GlobeNewswire January 31, 2022

36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022

ACCESS Newswire January 28, 2022

Aspira Women's Health Executes an Agreement with Axia Women's Health to Launch Aspira Synergy Genetics Platform

GlobeNewswire January 5, 2022

Aspira Women's Health Appoints Minh Merchant as General Counsel

GlobeNewswire January 5, 2022